Inari Medical Stock Piotroski F Score

NARI Stock  USD 51.03  0.20  0.39%   
This module uses fundamental data of Inari Medical to approximate its Piotroski F score. Inari Medical F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Inari Medical. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Inari Medical financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out Inari Medical Altman Z Score, Inari Medical Correlation, Inari Medical Valuation, as well as analyze Inari Medical Alpha and Beta and Inari Medical Hype Analysis.
For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.
  
As of now, Inari Medical's Cash Flow To Debt Ratio is increasing as compared to previous years. As of now, Inari Medical's Free Cash Flow Yield is increasing as compared to previous years. The Inari Medical's current Operating Cash Flow Per Share is estimated to increase to 0.66, while Price To Sales Ratio is projected to decrease to 7.09.
At this time, it appears that Inari Medical's Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
3.0
Piotroski F Score - Frail
Current Return On Assets

Negative

Focus
Change in Return on Assets

Decreased

Focus
Cash Flow Return on Assets

Positive

Focus
Current Quality of Earnings (accrual)

Improving

Focus
Asset Turnover Growth

Decrease

Focus
Current Ratio Change

Decrease

Focus
Long Term Debt Over Assets Change

Lower Leverage

Focus
Change In Outstending Shares

Increase

Focus
Change in Gross Margin

No Change

Focus

Inari Medical Piotroski F Score Drivers

The critical factor to consider when applying the Piotroski F Score to Inari Medical is to make sure Inari is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Inari Medical's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Inari Medical's financial numbers are properly reported.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.590.7321
Significantly Down
Slightly volatile
Gross Profit Margin0.70.8803
Significantly Down
Pretty Stable
Total Current Liabilities80.2 M76.3 M
Sufficiently Up
Slightly volatile
Non Current Liabilities Total139.6 M133 M
Sufficiently Up
Pretty Stable
Total Assets707.9 M674.2 M
Sufficiently Up
Slightly volatile
Total Current Assets215.4 M235.6 M
Significantly Down
Slightly volatile

Inari Medical F Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Inari Medical's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Inari Medical in a much-optimized way.

About Inari Medical Piotroski F Score

F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.

Book Value Per Share

8.6

As of now, Inari Medical's Book Value Per Share is increasing as compared to previous years.

Inari Medical Current Valuation Drivers

We derive many important indicators used in calculating different scores of Inari Medical from analyzing Inari Medical's financial statements. These drivers represent accounts that assess Inari Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Inari Medical's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap2.0B2.8B4.5B3.4B3.7B2.4B
Enterprise Value2.0B2.7B4.5B3.3B3.7B2.4B

Inari Medical ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Inari Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Inari Medical's managers, analysts, and investors.
Environmental
Governance
Social

About Inari Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Inari Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inari Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inari Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

When determining whether Inari Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inari Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inari Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inari Medical Stock:
Check out Inari Medical Altman Z Score, Inari Medical Correlation, Inari Medical Valuation, as well as analyze Inari Medical Alpha and Beta and Inari Medical Hype Analysis.
For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari Medical. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.84)
Earnings Share
(1.35)
Revenue Per Share
9.901
Quarterly Revenue Growth
0.214
Return On Assets
(0.03)
The market value of Inari Medical is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari Medical's value that differs from its market value or its book value, called intrinsic value, which is Inari Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari Medical's market value can be influenced by many factors that don't directly affect Inari Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inari Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inari Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.